Foghorn Therapeutics Inc. Common Stock FHTX
$4.92
+1.03%
at last close
Financials (TTM)
- Revenue
- $36.74 million
- Net Income
- $-64,579,000
- Net Margin
- -175.78%
- Return on Equity
- 79.69%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -3.61
- Price / Sales
- 7.95
Over the trailing twelve months, Foghorn Therapeutics Inc. Common Stock generated revenue of $36.74 million and net income of $-64,579,000, a net margin of -175.78%.
At the last closing price of $4.92, FHTX trades at 7.95 times sales, with a market capitalization of $292.18 million.
Key Stats
- Last Close
- $4.92
- Market Cap
- $292.18 million
- 52-Week Range
- $3.27 – $7.61
- Average Volume
- 332K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.